Stock ZOM ZOMEDICA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Zomedica Corp.

Equities

ZOM

CA98980M1095

Real-time Estimate Cboe BZX
Other stock markets
 10:13:57 2024-06-05 am EDT 		5-day change 1st Jan Change
0.157 USD +0.64% Intraday chart for Zomedica Corp. -5.96% -21.18%
Jun. 04 Zomedica Completes Expansion of Manufacturing, Distribution Facilities in Roswell, Georgia MT
May. 15 Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zomedica Completes Expansion of Manufacturing, Distribution Facilities in Roswell, Georgia
MT
Zomedica Enhances TRUFORMA Platform with Launch of Advanced Canine Cortisol Assay
AQ
Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA Platform
AQ
Zomedica Corp. Releases Over-The-Air Software Update Capabilities for Its Truforma(R) Platform
CI
Earnings Flash (ZOM) ZOMEDICA Posts Q1 Revenue $6.3M
MT
Zomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Zomedica Corp., Q1 2024 Earnings Call, May 09, 2024
Zomedica Corp. Provides Revenue Guidance for Full Year 2024
CI
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA Diagnostic Platform
AQ
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
AQ
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
AQ
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Zomedica Seeks Acquisitions
CI
Transcript : Zomedica Corp., Q4 2023 Earnings Call, Apr 01, 2024
Earnings Flash (ZOM) ZOMEDICA Posts Q4 Revenue $7.3M
MT
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024
CI
Zomedica Announces Publication of Research Concluding TRUFORMA Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay Platform
AQ
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform
CI
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
AQ
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZOM Stock
  4. News Zomedica Corp.